1 od 20
EBD Group
@
EBDgroup
4. velj
Speaking at
#BiotechShowcase
2020,
@jmaxlevin
, of
@OvidRx
gives an update the company's progress with its investigational medicine, OV101 (gaboxadol) for the treatment of Angelman syndrome and Fragile X syndrome >>
youtu.be/gRo_pOWcaec
@cglifeagency
@demycolton
Dalje